HDAC9 and neoplasm: This article systematically expounds for the first time the specific mechanism by which HDACs promote tumor radiotherapy resistance <i>in vivo</i> and <i>in vitro</i> and the clinical application prospects of HDAC inhibitors, aiming to provide a reference for HDAC-related drug development and guide the future research direction of HDAC inhibitors that improve tumor radiotherapy resistance.